Topic of the Week June 22nd to 28th 2020 RECOVERY Trial (Dexamethasone for COVID-19) Monday Villar. Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019. Crit Care Explor 2020;2(4):e0111 Tuesday Taboada. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease. J Clin Anesth 2020;66:109926 Wednesday Berton. Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view. J Endocrinol Invest 2020;epublished June 8th Thursday Matsuda. Corticosteroid therapy for severe COVID-19 pneumonia: optimal dose and duration of administration. Global Health & Medicine 2020;epublished May 30th Friday Matthay. Acute respiratory distress syndrome. Nat Rev Dis Primers 2019; 5(1):18 Saturday Arabi. Corticosteroid Therapy for Critically Ill Patients with the Middle East Respiratory Syndrome. Am J Respir Crit Care Med 2017;epublished November 21st Sunday Villar. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med 2020;8:267–76